SUmmARY A small ventricular septal defect in an 18 year old man was shown by serial cardiac catheterisation to be associated with a progressive increase in pulmonary arterial pressure. Surgical closure of the defect had no effect on the increased pulmonary arterial pressure. Whether pulmonary hypertension occurred secondary to the haemodynamics of the ventricular septal defect or as an independent event is uncertain. the auscultatory and laboratory findings were unchanged. Cardiac catheterisation (Table) showed a 35% left to right shunt, a mean pulmonary arterial pressure of 28 mm Hg, and normal pulmonary arterial resistance (Rp:Rs 0-20). He continued to be asymptomatic and at 16 years a grade 4/6 systolic murmur was still present in the third and fourth intercostal spaces along the left sternal border. A diastolic murmur was barely audible at the apex. The pulmonary component of the second heart sound was strongly accentuated. The electrocardiogram showed right ventricular hypertrophy and a thoracic radiograph cardiac enlargement and increased pulmonary arterial markings. Catheterisation (Table) showed a left to right shunt of 35%. The pulmonary arterial pressure was increased (86/47 mm Hg, mean 60 mm Hg). The pulmonary vascular resistance was raised and was nearly half of the systemic vascular resistance. The administration of tolazoline hydrochloride caused an increase in both pulmonary and systemic blood flow and a decrease in both systemic and pulmonary vascular resistance.
SUmmARY A small ventricular septal defect in an 18 year old man was shown by serial cardiac catheterisation to be associated with a progressive increase in pulmonary arterial pressure. Surgical closure of the defect had no effect on the increased pulmonary arterial pressure. Whether pulmonary hypertension occurred secondary to the haemodynamics of the ventricular septal defect or as an independent event is uncertain.
The natural history of uncomplicated ventricular septal defect has been well delineated,1-5 and most cardiologists agree on a general approach to the management of this condition. For children with ventricular septal defect, a left to right shunt less than 2:1 and a pulmonary arterial pressure less than 400/o of systemic pressures a corrective operation is rarely recommended. 6 We report the case of a patient with a small ventricular septal defect in whom progressive pulmonary vascular disease developed.
Case report
An 18 year old boy was first seen at the University of Minnesota Hospitals at the age of 4 years because of a murmur initially heard at 4 months of age. He was born at 35 weeks' gestation and weighed [2] [3] [4] [5] [6] kg. There were no prenatal illnesses, and the mother had received no drugs. There were no symptoms referrable to the cardiovascular system. At 4 years of age a grade 4/6 pansystolic murmur was audible along the left sternal border and a grade 2/6 diastolic murmur at the apex. The second heart sound was normal. The electrocardiogram showed "mild" biventricular hypertrophy. Cardiac catheterisation (Table) the auscultatory and laboratory findings were unchanged. Cardiac catheterisation (Table) showed a 35% left to right shunt, a mean pulmonary arterial pressure of 28 mm Hg, and normal pulmonary arterial resistance (Rp:Rs 0-20). He continued to be asymptomatic and at 16 years a grade 4/6 systolic murmur was still present in the third and fourth intercostal spaces along the left sternal border. A diastolic murmur was barely audible at the apex. The pulmonary component of the second heart sound was strongly accentuated. The electrocardiogram showed right ventricular hypertrophy and a thoracic radiograph cardiac enlargement and increased pulmonary arterial markings. Catheterisation (Table) showed a left to right shunt of 35%. The pulmonary arterial pressure was increased (86/47 mm Hg, mean 60 mm Hg). The pulmonary vascular resistance was raised and was nearly half of the systemic vascular resistance. The administration of tolazoline hydrochloride caused an increase in both pulmonary and systemic blood flow and a decrease in both systemic and pulmonary vascular resistance. The critical problem is the difficulty in deciding whether the vascular changes occurred secondary to the ventricular septal defect or as a primary phenomenon. It is impossible to distinguish histologically between the findings in obstructive pulmonary vascular disease secondary to a left to right shunt and those observed in the late stages of primary pulmonary hypertension.8 When a ventricular septal defect is present pulmonary vascular disease is usually considered to be secondary to the septal defect, but this association must be questioned when the defect is small.
Severe pulmonary vascular disease has been reported in patients with a spontaneously closed ventricular septal defect.910 In each patient, however, the ventricular septal defect was initially either of moderate size or large. Therefore the presumed large shunt could have initiated pulmonary vasoconstriction and the subsequent pulmonary vascular disease. Once the process of pulmonary vascular disease has been started it may be unnecessary after a certain stage for the stimulus for the vascular disease to be sustained.
In our patient the ventricular septal defect was closed surgically. Although pulmonary vascular disease develops after surgical closure of a ventricular septal defect," the defects are usually large and the pulmonary arterial pressure increased from early life.
The case of our patient with a small ventricular septal defect is, therefore, unusual and presents a rare event-the development of pulmonary vascular disease. Whether the pulmonary hypertension occurred secondary to the haemodynamic effects of the ventricular septal defect or as an independent event-that is, primary pulmonary hypertension-is uncertain.
We consider that patients with a small ventricular septal defect should be investigated every five years but do not feel this frequency needs to be increased because of the rare occurrence of pulmonary hypertension. Supported by the Dwan Cardiovascular Learning Center, University of Minnesota Hospitals, Minneapolis, Minnesota. 
